14 October 2012
Global market for reid in healthcare, pharma to reach $1.7 BLN BY 2018
Steven Johnson, Healthcare Global
The new global report was released by a publisher of off-the-shelf market research namely Global Industry Analyts, Inc announcing that the global market for RFID in healthcare and pharmaceutical markets will reach $1.7 billion by the year 2018.
14 October 2012
Strong pharma research is key to bringing in investment
Pharma Letter
“Few people disagree that small drug discovery companies are vital to the health of the UK's pharma industry, and central to the government's aim of innovation-led growth. But private backers have become increasingly risk-averse," said Ana Nicholls, Healthcare Analyst at the Economist Intelligence Unit in response to an article in the UK’s Financial Times yesterday, titled Pioneering research on drugs is key to clinching investment.
CoDa Therapeutics, Inc. announced that it has raised $19.2 million in a Series B financing.
San Diego, California - April 18, 2011 - CoDa Therapeutics, Inc. announced today that it has raised $19.2 million in a Series B financing.
The RMI group has completed sertain projects
The RMI Group has exited from the capital of portfolio companies:
Marinus Pharmaceuticals, Inc.,
Syndax Pharmaceuticals, Inc.,
Atea Pharmaceuticals, Inc.